BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 20565749)

  • 21. Transfection of an inducible p16/CDKN2A construct mediates reversible growth inhibition and G1 arrest in the AtT20 pituitary tumor cell line.
    Frost SJ; Simpson DJ; Clayton RN; Farrell WE
    Mol Endocrinol; 1999 Nov; 13(11):1801-10. PubMed ID: 10551774
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experimental study on inhibition effects of the XAF1 gene against lung cancer cell proliferation.
    Yang WT; Chen DL; Zhang FQ; Xia YC; Zhu RY; Zhou DS; Chen YB
    Asian Pac J Cancer Prev; 2014; 15(18):7825-9. PubMed ID: 25292071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of cell cycle proteins in 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced mouse lung tumors.
    Sabourin CL; Wang QS; Ralston SL; Evans J; Coate J; Herzog CR; Jones SL; Weghorst CM; Kelloff GJ; Lubet RA; You M; Stoner GD
    Exp Lung Res; 1998; 24(4):499-521. PubMed ID: 9659580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FBXL16 is a novel E2F1-regulated gene commonly upregulated in p16INK4A- and p14ARF-silenced HeLa cells.
    Sato K; Kusama Y; Tategu M; Yoshida K
    Int J Oncol; 2010 Feb; 36(2):479-90. PubMed ID: 20043084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Concomitant expression of p16INK4a and p14ARF in primary breast cancer and analysis of inactivation mechanisms.
    Silva J; Silva JM; Domínguez G; García JM; Cantos B; Rodríguez R; Larrondo FJ; Provencio M; España P; Bonilla F
    J Pathol; 2003 Mar; 199(3):289-97. PubMed ID: 12579530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of 5-aza-2'-deoxycytidine on cell proliferation of non- small cell lung cancer cell line A549 cells and expression of the TFPI-2 gene.
    Dong YQ; Liang JS; Zhu SB; Zhang XM; Ji T; Xu JH; Yin GL
    Asian Pac J Cancer Prev; 2013; 14(7):4421-6. PubMed ID: 23992014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of exogenous p16 gene on biological behaviors of human lung cancer].
    Bai M; Jin Y; Zhang X
    Zhonghua Jie He He Hu Xi Za Zhi; 2001 Aug; 24(8):465-8. PubMed ID: 11718035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [p16INK4a expression mediated by recombinant adenovirus can induce senescence of A549 cells].
    Bai XY; Che FX; Chen XM; Meng LY; Zhou Y
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Mar; 18(1):54-8. PubMed ID: 15340528
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exogenous expression of p16INK4a is associated with decrease in telomerase activity.
    Sawa H; Kamada H; Ohshima TA; Noguchi A; Itoh N; Saruta K; Hara M; Saito I
    J Neurooncol; 1999 Mar; 42(1):45-57. PubMed ID: 10360478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CDKN2A unclassified variants in familial malignant melanoma: combining functional and computational approaches for their assessment.
    Scaini MC; Minervini G; Elefanti L; Ghiorzo P; Pastorino L; Tognazzo S; Agata S; Quaggio M; Zullato D; Bianchi-Scarrà G; Montagna M; D'Andrea E; Menin C; Tosatto SC
    Hum Mutat; 2014 Jul; 35(7):828-40. PubMed ID: 24659262
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms of p16INK4A inactivation in non small-cell lung cancers.
    Gazzeri S; Gouyer V; Vour'ch C; Brambilla C; Brambilla E
    Oncogene; 1998 Jan; 16(4):497-504. PubMed ID: 9484839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. P16Ink4a tumor suppressor function in lung cancer cells involves cyclin-dependent kinase 2 inhibition by Cip/Kip protein redistribution.
    Grimison B; Langan TA; Sclafani RA
    Cell Growth Differ; 2000 Oct; 11(10):507-15. PubMed ID: 11063124
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lower expression of p14ARF and p16INK4a correlates with higher DNMT3B expression in human oesophageal squamous cell carcinomas.
    Simão Tde A; Simões GL; Ribeiro FS; Cidade DA; Andreollo NA; Lopes LR; Macedo JM; Acatauassu R; Teixeira AM; Felzenszwalb I; Pinto LF; Albano RM
    Hum Exp Toxicol; 2006 Sep; 25(9):515-22. PubMed ID: 17017004
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms of G1 checkpoint loss in resected early stage non-small cell lung cancer.
    Zhou JX; Niehans GA; Shar A; Rubins JB; Frizelle SP; Kratzke RA
    Lung Cancer; 2001 Apr; 32(1):27-38. PubMed ID: 11282426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro study examining the effect of sub-lethal QS 755 nm lasers on the expression of p16INK4a on melanoma cell lines.
    Chan HH; Xiang L; Leung JC; Tsang KW; Lai KN
    Lasers Surg Med; 2003; 32(2):88-93. PubMed ID: 12561040
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic alterations of p16INK4a and p14ARF genes in human bladder cancer.
    Chang LL; Yeh WT; Yang SY; Wu WJ; Huang CH
    J Urol; 2003 Aug; 170(2 Pt 1):595-600. PubMed ID: 12853838
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A new system for regulated functional gene expression for gene therapy applications: nuclear delivery of a p16INK4A-estrogen receptor carboxy terminal fusion protein only in the presence of estrogen.
    Tamura T; Kanuma T; Nakazato T; Faried LS; Aoki H; Minegishi T
    Int J Oncol; 2010 Apr; 36(4):905-12. PubMed ID: 20198335
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oligodendroglial tumors frequently demonstrate hypermethylation of the CDKN2A (MTS1, p16INK4a), p14ARF, and CDKN2B (MTS2, p15INK4b) tumor suppressor genes.
    Wolter M; Reifenberger J; Blaschke B; Ichimura K; Schmidt EE; Collins VP; Reifenberger G
    J Neuropathol Exp Neurol; 2001 Dec; 60(12):1170-80. PubMed ID: 11764089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The co-transfection of p16(INK4a) and p14(ARF) genes into human lung cancer cell line A549 and the effects on cell growth and chemosensitivity.
    Xie QC; Hu YD; Wang LL; Chen ZT; Diao XW; Wang ZX; Guan HJ; Zhu B; Sun JG; Duan YZ; Chen FL; Nian WQ
    Colloids Surf B Biointerfaces; 2005 Dec; 46(3):188-96. PubMed ID: 16337111
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Disfigurement of p16INK4A gene expression in development of ovarian cancer and the mechanism].
    Li M; Huang ZJ; Dong WH; Li XY; Wang XY; He XH; Wang H; Wang ZH
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jun; 41(6):408-12. PubMed ID: 16831366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.